MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma

por Loeuillard, Emilien, Gores, Gregory J., Ilyas, Sumera I.
Publicado 2021

IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids

por Garcia Moreno, Ana Sofia, Guicciardi, Maria Eugenia, Wixom, Alexander Q., Jessen, Erik, Yang, Jingchun, Ilyas, Sumera I., Bianchi, Jackie K., Pinto e Vairo, Filippo, Lazaridis, Konstantinos N., Gores, Gregory J.
Publicado 2023

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma

por Miyabe, Katsuyuki, Chandrasekhara, Vinay, Wongjarupong, Nicha, Chen, Jun, Yang, Lu, Johnson, Stephen, Chia, Nicholas, Walther-Antonio, Marina, Yao, Janet Z., Harrington, Sean C., Nordyke, Cynthia K., Eaton, John E., Gossard, Andrea A., Oli, Sharad, Ali, Hamdi A., Lavu, Sravanthi, Giama, Nasra H., Hassan, Fatima A., Ali, Hawa M., Enders, Felicity T., Ilyas, Sumera I., Gores, Gregory J., Topazian, Mark D., Kashyap, Purna C., Roberts, Lewis R.
Publicado 2022